Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation
Frontiers in Endocrinology · 2024
DOI: 10.3389/fendo.2024.1361707 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Endocrinology, 2024. Verfasst von Xianhua Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Alanine Transaminase, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Aspartate Aminotransferases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
This study aimed to explore the association between the aspartate aminotransferase to alanine aminotransferase ratio (AST/ALT ratio) and diabetic retinopathy (DR) in patients with type 2 diabetes.
Methods
In this cross-sectional study, clinical data from 3002 patients with type 2 diabetes admitted to the Department of Endocrinology of our hospital between January 1, 2021, and December 1, 2022, were retrospectively collected. Measurements of AST and ALT were conducted and diabetes-related complications were screened. The association between AST/ALT ratio and diabetic retinopathy was assessed using multivariate logistic regression, and a generalized additive model (GAM) was used to investigate nonlinear relationships. Subgroup analyses and interaction tests were also conducted.
Results
Among the 3002 patients, 1590 (52.96%) were male and 1412 (47.04%) were female. The mean AST/ALT ratio was 0.98 ± 0.32, ranging from 0.37 (Min) to 2.17 (Max). Diabetic retinopathy was present in 40.47% of the patients. After multivariate adjustments, for each 0.1 unit increase in AST/ALT ratio, the risk of DR increased by 4% (OR = 1.04, 95% CI: 1.01–1.07, p=0.0053). Higher AST/ALT ratio quartiles were associated with Higher prevalence of DR (OR vs . Q1: Q4 = 1.34 (CI: 1.03–1.75, p=0.0303).The GAM and smoothed curve fit indicated a linear relationship between AST/ALT ratio and DR risk, with no significant interaction effects across different subgroups.
Conclusion
Our study demonstrates a positive correlation between the AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes, suggesting its potential role in assessing DR risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Nursing and Hospital Infection Management, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Endocrinology and Diabetes Department, Shouguang People's Hospital, Weifang, Shandong, China.
Zitieren
APA
Li, X., Hao, W., Lin, S., & Yang, N. (2024). Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1361707
Vancouver
Li X, Hao W, Lin S, Yang N. Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation. Frontiers in Endocrinology. 2024. doi:10.3389/fendo.2024.1361707
BibTeX
@article{Li2024,
author = {Li, Xianhua and Hao, Wenqing and Lin, Sen and Yang, Nailong},
title = {Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation},
journal = {Frontiers in Endocrinology},
year = {2024},
doi = {10.3389/fendo.2024.1361707}
}
EUVIMED